HBM BioVentures has started sales negotiations for several portfolio companies and is participating actively in the selling processes. As demand from major pharma and biotech companies for new products continues to rise, and with many mature portfolio companies, HBM BioVentures is well positioned for successful divestments.

HBM BioVentures’ investment activity is currently focused on follow-on financing for existing portfolio companies. Each individual financing round is analysed in detail from the scientific, technical, business, financial, legal and patent perspectives. Investments are made only in companies that have attractive value-creation potential. HBM BioVentures takes an active role and entrepreneurial responsibility in each of the 20 largest private portfolio companies.